×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACXP – acurx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:00 am
acxp
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
Low
Report
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
11/15
07:05 pm
acxp
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
Medium
Report
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television [Yahoo! Finance]
11/12
07:21 am
acxp
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
High
Report
Acurx Pharmaceuticals GAAP EPS of -$1.23 beats by $0.05 [Seeking Alpha]
11/12
07:01 am
acxp
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
High
Report
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
11/10
08:43 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
High
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens [Yahoo! Finance]
11/10
08:00 am
acxp
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
Medium
Report
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
10/28
08:00 am
acxp
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
Medium
Report
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
06:36 pm
acxp
Form SCHEDULE 13G/A Acurx Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G/A Acurx Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
11/12
07:01 am
acxp
Form 10-Q Acurx Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q Acurx Pharmaceuticals, For: Sep 30
11/10
05:16 pm
acxp
Form 424B3 Acurx Pharmaceuticals,
Medium
Report
Form 424B3 Acurx Pharmaceuticals,
10/20
05:26 pm
acxp
Form S-1 Acurx Pharmaceuticals,
Low
Report
Form S-1 Acurx Pharmaceuticals,
9/22
04:42 pm
acxp
Form 8-K Acurx Pharmaceuticals, For: Sep 22
Low
Report
Form 8-K Acurx Pharmaceuticals, For: Sep 22
9/19
05:16 pm
acxp
Form 8-K Acurx Pharmaceuticals, For: Sep 16
Low
Report
Form 8-K Acurx Pharmaceuticals, For: Sep 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: